Fountain Life offers comprehensive longevity diagnostics—but at $19,500+ annually, it's not right for everyone. Here's how to find the program that matches your specific health goals and budget.
Last updated: January 28, 2026
Fountain Life, co-founded by Peter Diamandis and Tony Robbins, positions itself as a "health assurance" company focused on early disease detection through advanced imaging. Their APEX membership includes:
This comprehensive approach has obvious appeal. However, the annual commitment of $19,500-$21,500 creates a barrier that leads many to seek alternatives.
| Program | Annual Cost | Focus | Best For |
|---|---|---|---|
| Fountain Life APEX | $19,500+ | Full-body screening, early detection | Maximum diagnostic breadth |
| Fountain Life CORE | $2,995 | Quarterly labs, telemedicine | Budget entry to longevity medicine |
| Human Longevity Inc | $25,000+ | Genomics, imaging, precision medicine | Genetics-focused assessment |
| Next Health | $300-5,000 | À la carte services, IV therapy | Wellness optimization, recovery |
| Forward | $149/mo | Tech-enabled primary care | Accessible preventive care |
| GRN Labs Protocol | $5,000 | Vascular restoration, 12-week program | Targeted vascular/ED intervention |
Fountain Life excels at breadth—scanning for abnormalities across every organ system. This "find everything" approach is valuable for comprehensive baseline assessment.
However, identifying a problem is only step one. Many executives leave their Fountain Life assessment with a list of findings but no clear intervention path. The program diagnoses; it doesn't necessarily treat.
Longevity centers like Fountain Life focus on early detection—finding disease before symptoms appear. This is reactive, even if early.
A different philosophy emphasizes functional optimization—improving the underlying systems to prevent dysfunction from developing. Programs focused on biomarker optimization, vascular health, or metabolic function take this proactive approach.
If your primary concerns are brain fog, fatigue, declining energy, or erectile dysfunction, these symptoms often share a common root: vascular and endothelial dysfunction.
Rather than screening every organ for disease, the GRN Protocol focuses on restoring the functional capacity of your vascular system over 12 weeks. At $5,000 for the complete program—about 25% of Fountain Life's annual cost—it delivers targeted intervention with measurable biomarker improvement.
Includes: Advanced biomarker panel (including ADMA), executive mobile phlebotomy, custom supplement protocol, bi-weekly reassessment, and optional continuation monitoring.
These options aren't mutually exclusive. Many executives benefit from periodic comprehensive screening (every 2-3 years) combined with ongoing targeted optimization programs.
A Fountain Life scan might identify early coronary plaque. A focused vascular program then addresses the underlying endothelial dysfunction that caused it. The diagnostic approach and the therapeutic approach serve different purposes.
Ready for a focused, results-driven approach to vascular health?
Apply for a Vascular ReviewThis comparison is for informational purposes only. Pricing and program details are based on publicly available information and may change. GRN Labs is not affiliated with Fountain Life, Human Longevity Inc, Next Health, or Forward. Consult with healthcare providers to determine the appropriate screening or intervention approach for your individual needs.